Mind Meld: How Intellectually Diverse Teams Can Drive Resilience And Better Outcomes  

By Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC

Biotechnology, especially of late, requires us to prevail over adversity to deliver for patients.  Spero, dedicated to new solutions for patients with infections, has been no exception. In May, we undertook a difficult, but necessary restructuring after a regulatory setback to our lead program tebipenem. In the four months since then, we have re-focused our team and strategy, advanced tebipenem to a key regulatory milestone, and closed a transformative partnership with GSK to develop and commercialize tebipenem. The partnership enables us…